| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.03 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |